Advertisement

Related Videos

S. Vincent Rajkumar, MD, on Cost-Effective Treatment of Multiple Myeloma

David A. Hyman, MD, JD, on Inclusive Shared Savings

Mark Sculpher, PhD: How Do We Assess the Value of Cancer Drug Optimization?

David T. Rubin, MD, on Biosimilars for Inflammatory Bowel Disease

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Advertisement

Advertisement




Jul
21
Today In Oncology
Integrating Environmental Health Into Pediatric Cancer Care May Improve Outcomes
Long-Term Outcomes With SABR in Primary Kidney Cancer
Long-Term Follow-up of Postoperative Chemoradiotherapy With Weekly vs Every-3-Week Cisplatin in Head and Neck Cancer
EMERALD-3 Shows Benefit With STRIDE Plus TACE in Hepatocellular Carcinoma
Mutant KRAS Vaccine for Prevention of Pancreatic Cancer Development Shows Durable Immune Responses
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo